- Products & Services
- Knowledge Base
WASHINGTON, DC, May 06, 2021 /24-7PressRelease/ -- APIQUEST-USA, a company registered in The United States, is pleased to announce its intention to initiate several clinical trials to study the efficacy and safety of Apivirine for the prevention and treatment of COVID19 infection. Apivirine is an herbal product extracted from the Dichrostachys Glomerata plant, one of the most widely used herbal medicines in tropical regions of the world. It is primarily found in tropical Africa and India, and all parts of the plant are used except the inflorescences.
Apivirine has been used for nearly 20 years for the treatment of HIV / AIDS in Africa and recently showed encouraging signs in the treatment of COVID19 in Burkina Faso, Africa, where a recent clinical trial took place in the University of Burkina Faso. Apivirine is currently being evaluated as a cure for covid-19 for active clinical trials (phase III) in South Africa, Ghana, and Canada. According to Professor Martial Ouédraogo, the study by the University of Burkina Faso, commissioned by the Government of Burkina Faso, "demonstrated the efficacy and safety of Apivirine in the curative treatment of covid-19 in 45 patients in this regard. They were all cured after an early improvement in their condition .... several patients whose clinical pictures were hopeless cases with complications such as pulmonary embolism, high blood pressure, diabetes, etc., were all cured with Apivirine within a short period of time."
The World Health Organization (WHO) recognizes that traditional medicine has many benefits and welcomes innovation in new therapies to seek potential treatments for COVID-19. Although scientific research is currently being conducted at the University of Toledo in Ohio, it is in this vein that APIQUEST-USA is collaborating with American institutions to confirm the efficacy and safety of apivirine through phase 3 clinical trials with a large population included.
Mbaye Diagne, CEO of APIQUEST-USA, said: "As an over-the-counter nutraceutical that comes in syrup form for children and capsule form, we believe we have an additional tool in addition to promising vaccines to combat COVID-19. We have submitted requests to the US government. (i.e., the US military) for clinical trials. Getting the results is essential to speed up the approval process. The number of American citizens affected by this disease is alarming compared to other countries globally, and we want to make a difference from a humanitarian point of view."
APIQUEST, –APIQUEST-USA is a minority-owned company incorporated in the State of Delaware. The company is focused on solutions to eradicate the deadly COVID-19 pandemic and ensure that what lies beyond the pandemic will be better than what was before... better for business, better for the environment, and better for members of society. The virus has killed more than 576,000 in the United States and more than 3,193,000 worldwide. APIQUEST-USA has signed an exclusive agreement with Dr. Valentin Agon, world-renowned African doctor and researcher, graduate of UQAR University of Quebec in Rimouski in Canada, owner of APIVIRINE. This natural antiviral drug has been shown to be useful with many deadly viruses, including HIV-AIDS. To this end, APIQUEST USA is moving ahead with various partners to prove the efficacy of Apivirine as a treatment of COVID-19.
# # #